Scannell Timothy J — SEC Form 4 filings
SEC reporting owner CIK 1451533. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-05-23 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 20,208 shares, $3,146,511 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 7,000 shares @ $190.51 ($1,333,570) in INSULET CORP, filed 2024-06-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSULET CORP (PODD) | Director | 6 | — | 3 legs · 15,300 sh · $3,059,740 | 11 |
| NovoCure Ltd (NVCR) | Director | 5 | — | 3 legs · 4,908 sh · $86,771 | 6 |
| MASIMO CORP (MASI) | Director | 4 | — | — | 9 |
Form 4 filings — Scannell Timothy J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | MASIMO CORP (MASI) | Disposition to issuer (D): 2,608 @ $180 · Disposition to issuer (D): 1,119 (derivative) | EDGAR |
| 2026-06-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-05-21 | 4 | INSULET CORP (PODD) | Grant/award (A): 1,660 @ $0 | EDGAR |
| 2026-05-05 | 4 | MASIMO CORP (MASI) | Option exercise (M): 1,225 @ $0 · Option exercise (M): 1,225 (derivative) @ $0 · Grant/award (A): 1,119 (derivative) @ $178.71 | EDGAR |
| 2025-06-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,215 @ $0 · Grant/award (A): 16,697 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 999 @ $17.32 | EDGAR |
| 2025-05-27 | 4 | INSULET CORP (PODD) | Grant/award (A): 778 @ $0 | EDGAR |
| 2025-05-02 | 4 | MASIMO CORP (MASI) | Option exercise (M): 1,383 @ $0 · Option exercise (M): 1,383 (derivative) @ $0 · Grant/award (A): 1,225 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | MASIMO CORP (MASI) | Grant/award (A): 1,383 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | INSULET CORP (PODD) | Sale (S): 5,000 @ $225.84 | EDGAR |
| 2024-06-11 | 4 | INSULET CORP (PODD) | Sale (S): 7,000 @ $190.51 | EDGAR |
| 2024-06-06 | 4 | NovoCure Ltd (NVCR) | Sale (S): 964 @ $23.89 · Grant/award (A): 4,053 @ $0 · Grant/award (A): 6,229 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | INSULET CORP (PODD) | Option exercise (M): 3,920 @ $36.38 · Option exercise (M): 5,525 @ $27.37 · Option exercise (M): 5,235 @ $28.87 · Option exercise (M): 3,587 @ $40.60 · Sale (S): 3,300 @ $180.90 · Option exercise (M): 3,920 (derivative) @ $0 · +3 more | EDGAR |
| 2024-05-23 | 4 | INSULET CORP (PODD) | Grant/award (A): 1,380 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1451533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →